ProPhase Labs, Inc.
PRPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $19 | $16 | $8 | $15 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $8 | $8 | $14 | $25 |
| Enterprise Value | $26 | $24 | $22 | $39 |
| Revenue | $1 | $1 | $1 | -$2 |
| % Growth | -29.2% | -12.9% | 157.6% | – |
| Gross Profit | -$0 | $1 | $1 | $1 |
| % Margin | -13.9% | 58.9% | 36.8% | -37.2% |
| EBITDA | -$4 | -$4 | -$3 | -$14 |
| % Margin | -497.4% | -286% | -177.2% | 576.4% |
| Net Income | -$7 | -$4 | $4 | -$34 |
| % Margin | -774.5% | -358.6% | 277.1% | 1,383.2% |
| EPS Diluted | -0.16 | -0.11 | 0.21 | -1.58 |
| % Growth | -45.5% | -152.4% | 113.3% | – |
| Operating Cash Flow | -$22 | -$0 | -$3 | $2 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$22 | -$0 | -$3 | $2 |